Benzothiazole, 7-Bromo-

What Limits Sulfenamide Acceleration When Bromine Occupies the 7-Position?

Incorporation of 7-Bromo-Benzothiazole into sulfenamide-based accelerator systems for sulfur-vulcanized natural rubber (NR) and styrene-butadiene rubber (SBR) compounds modifies the scorch delay profile through electron-withdrawing effects exerted by the bromine substituent on the thiazole ring. In production-scale internal mixers (e.g., Banbury F270 with a net chamber volume of 270 L and 4-wing rotor configuration operating at 40-60 rpm), the compound is introduced at a dosage of 0.15-0.40 phr (parts per hundred rubber) in conjunction with N-cyclohexyl-2-benzothiazolesulfenamide (CBS) at 0.9-1.2 phr and sulfur at 1.8-2.3 phr. The halogenated intermediate acts not as a primary accelerator but as an activity modulator, extending Mooney scorch time (MS t5 at 121°C per ASTM D1646) by 3.2-5.8 minutes relative to CBS-only controls without sacrificing cure rate index (CRI) calculated from moving die rheometer (MDR) data at 160°C arc 0.5° per ASTM D5289-17. Industry compliance for finished rubber articles intended for repeated food contact applications in the EU mandates migration testing under Regulation (EU) No. 10/2011 with specific migration limit (SML) verification; in the United States, 21 CFR 177.2600 governs rubber articles for repeated use, and the brominated species must demonstrate total extractives below 7.0 mg/in² of article surface. Downstream processing employs a two-roll mill with a nip gap of 1.8-2.5 mm and front-to-back roll friction ratio of 1:1.15, followed by compression molding at 155-165°C under 15-20 MPa platen pressure for vulcanization times determined by MDR t90 rheometer data plus 2 minutes per mm of part thickness. Terminal products include extruded automotive weatherstrip profiles with closed-cell EPDM foam cores, gaskets for industrial plate heat exchangers operating continuously at 120°C in contact with demineralized water, and tire innerliner compound formulations where bromobutyl rubber blends require halogen compatibility to maintain air retention rates below 2.5% pressure loss per month as measured by ASTM F1112-20.

Operational boundaries require strict moisture exclusion: the brominated thiazole undergoes hydrolytic degradation when exposed to relative humidity exceeding 55% at ambient temperatures above 28°C, yielding 7-hydroxy-benzothiazole derivatives that exhibit negligible accelerator-modulating activity and, in concentrations above 0.05 wt%, initiate premature crosslinking detectable as a rise in minimum MDR torque by 0.4-0.7 dN·m. Storage protocol specifies sealed, nitrogen-purged containers maintained at 10-22°C with desiccant indicators; drums opened for partial withdrawal must be re-purged within 45 minutes of exposure to ambient plant atmosphere. Published data for the interaction of this specific congener with tetramethylthiuram disulfide (TMTD)-based systems is limited, and plant trials indicate potential antagonism at TMTD loadings above 0.6 phr manifesting as cure reversion rates exceeding 3% torque loss within 10 minutes post-t90.

When High-Shear Thermoplastic Extrusion Demands Halogen-Stable UV Quenching

Polyolefin monofilament extrusion for agricultural shade netting operating at line speeds of 180-280 m/min through single-screw extruders with 33:1 L/D ratio and Maddock mixing sections incorporates 7-Bromo-Benzothiazole as a UV-induced radical scavenger at addition levels of 0.08-0.22 wt% relative to polymer matrix weight. The compound is pre-dispersed in a linear low-density polyethylene (LLDPE, MFI 3.5 g/10 min at 190°C/2.16 kg per ISO 1133-1:2022) carrier concentrate at 8-12 wt% active loading, pelletized through a strand pelletizer with water bath temperature maintained at 18-22°C to prevent crystallite formation exceeding 0.25 mm mean diameter that would cause melt filtration screen blockage at mesh sizes finer than 325 mesh. During blown film coextrusion for three-layer greenhouse covers (LDPE/EVA/LDPE structure with total thickness 180-220 μm), the additive migrates preferentially toward the outer skin layer during processing, with confocal Raman microscopy confirming a concentration gradient of 1.7:1 outer-to-inner surface ratio at steady-state production after 40 minutes of continuous operation on a 3-layer die with 250 mm diameter and 1.8 mm die gap. Regulatory conformance under the European Construction Products Regulation (CPR) No. 305/2011 for geotextile applications requires durability testing per EN 12224:2000 (Method A, xenon-arc exposure at 50 MJ/m² radiant energy) with retained tensile strength per EN ISO 10319:2015 exceeding 80% of virgin values; formulations containing the brominated quencher at 0.18 wt% are documented in publicly available technical datasheets to achieve 84-91% retention across 12-month equatorial outdoor exposure trials in Southeast Asian test farms. The finished converter product range spans high-density polyethylene raschel-knit shade netting with 30-90% optical shading factor, extruded polypropylene twine for trellised tomato cultivation requiring 3-5 season service life, and coextruded LDPE/HDPE/LDPE mulch films where the brominated stabilizer reduces photo-oxidative embrittlement measured as carbonyl index increase per ASTM D5576-22 for films in direct soil contact at 30-50 μm gauge.

A critical process conflict emerges in cast-film production for stretch wrap applications: the exothermic decomposition of 7-Bromo-Benzothiazole initiates at 248°C (differential scanning calorimetry at 10°C/min ramp under nitrogen) and generates bromine radicals that, in melt residence times exceeding 110 seconds at adapter zones above 235°C, cause brown discoloration measured as Yellowness Index (YI) increase of 4.2-6.8 units per ASTM E313-20. This limits the additive's applicability to polymer grades processed below 225°C melt temperature, effectively excluding polypropylene homopolymer extrusion grades with MFI below 2.0 g/10 min and high-density polyethylene grades requiring plastication temperatures above 230°C for full melting. Migration testing under FDA 21 CFR 175.105 for indirect food contact adhesives and coatings has been completed for the neat compound with n-heptane and 8% ethanol food simulants at 66°C for 2 hours, demonstrating extractives not to exceed 0.05 mg/dm², though published compliance data for multilayer structures where the additive is embedded in a core layer are limited and require case-by-case Total Nonvolatile Extractives (TNVE) quantification per 21 CFR 177.1520(c) for olefin polymers.

Copper Circuit Etch-Resist Chemistry and the Alkaline Stripping Step

Within dry film photoresist lamination processes for printed circuit board (PCB) innerlayer fabrication on FR-4 epoxy-glass substrates with 18-35 μm copper foil, 7-Bromo-Benzothiazole serves as a heterocyclic corrosion inhibitor component in the pre-etch microetch step immediately preceding photoresist application. The compound is formulated at 1.2-2.5 g/L in aqueous sodium persulfate microetch solution (60-90 g/L Na₂S₂O₈, sulfuric acid to pH 0.8-1.2) and operates at a bath temperature of 28-32°C with conveyorized spray contact time of 25-40 seconds on horizontal equipment (e.g., Chemcut CC8000 series with double-sided oscillating spray manifolds operating at 1.4-2.0 kg/cm² nozzle pressure). During this dwell period, the brominated benzothiazole forms a monomolecular chemisorbed film on copper surfaces with an adsorption isotherm conforming to the Temkin model, achieving 94-97% surface coverage as characterized by X-ray photoelectron spectroscopy (XPS) detection of Cu 2p₃/₂ satellite peak suppression. Upon subsequent aqueous developable dry film photoresist lamination (acrylate-based, negative-tone, 38-50 μm thickness), the inhibitor layer persists through the dry film hot roll lamination step at 105-115°C with 0.5-0.8 m/min line speed and prevents copper oxidation at the resist-copper interface that would otherwise manifest as pink-ring defects visible after 48-hour ambient storage per IPC-A-600 Class 2 acceptance criteria. Compliance for PCB materials is governed by IPC-4101E specification sheets, with ionic cleanliness testing per IPC-TM-650 Method 2.3.25 requiring sodium chloride equivalent contamination below 1.56 μg/cm²; the brominated inhibitor must be fully removable during the alkaline developing step ( 1.0 wt% Na₂CO₃ at 30°C for 45-60 seconds) or subsequent cupric chloride acidic etching, or residue-induced electromigration failures become detectable in surface insulation resistance (SIR) testing at 85°C/85% RH under 100V DC bias for 168 hours per IPC-TM-650 Method 2.6.3.7.

An operational incompatibility documented on horizontal alkaline etching lines employing ammoniacal cupric chloride etchant (pH 8.5-9.2, Cu²⁺ concentration 150-180 g/L, free ammonia 6-8 g/L, operating temperature 48-52°C) manifests when the inhibitor is carried over into the etching chamber at concentrations exceeding 15 mg/L: the brominated heterocycle undergoes ammonolysis at the 2-position of the thiazole ring, generating 2-aminobenzothiazole derivatives that complex with dissolved copper and form a gelatinous precipitate depositing on spray nozzles and chamber walls, requiring line shutdown for 2-4 hours of citric acid-based descaling every 8-10 operating shifts. Terminal PCB types produced with this inhibitor chemistry include multilayer boards with 4-12 conductive layers for telecommunications backplane applications where innerlayer bond integrity must withstand 6× thermal stress at 288°C solder float per IPC-TM-650 Method 2.6.8, high-density interconnect (HDI) boards with 75-100 μm line width/spacing for mobile device applications fabricated via modified semi-additive processing, and rigid-flex assemblies where the microetched surface profile of 0.8-1.5 μm Ra roughness contributes to peel strengths exceeding 0.8 N/mm for polyimide flexible layers bonded to FR-4 stiffeners.

Immersion silver plating for high-frequency RF PCB applications operating above 10 GHz represents an alternative finish path where 7-Bromo-Benzothiazole is dissolved in the pre-dip solution preceding silver deposition at 0.5-1.0 g/L in deionized water with 2-5 vol% isopropyl alcohol as wetting agent, immersion time 60-90 seconds at 40-45°C. The pre-dip formulation intentionally displaces adsorbed chloride ions from the copper surface that originate from cupric chloride microetch steps, preventing silver chloride formation at the immersion silver bath interface that produces microvoids detectable in cross-sectional SEM analysis as sub-micron discontinuities in the 0.2-0.5 μm silver deposit. High-frequency insertion loss testing per IPC-TM-650 Method 2.5.5.13 at 40 GHz demonstrates that silver chloride-free finishes maintain a S₂₁ transmission coefficient within 0.08 dB of theoretical smooth copper values for microstrip structures, whereas silver chloride-contaminated deposits introduce 0.35-0.50 dB of frequency-dependent excess loss attributable to the semiconducting nature of AgCl interfacial films. Published process window data stipulate that pre-dip bath life is limited to 8 hours or 120 m² of processed panel area per liter of bath volume, whichever occurs first, beyond which 7-Bromo-Benzothiazole oxidative degradation products accumulate and promote, rather than prevent, interfacial corrosion during subsequent 155°C accelerated aging per IPC-4556 specification for immersion silver thickness verification.

A Mid-Chain Brominated Intermediate for Pharmaceutical API Synthesis

In the convergent synthesis of 2-aminobenzothiazole pharmacophores bearing halogen substituents, 7-Bromo-Benzothiazole undergoes Buchwald-Hartwig amination at the 2-position using palladium acetate (0.5-2.0 mol%) and Xantphos ligand (1.5-4.0 mol%) in refluxing 1,4-dioxane with sodium tert-butoxide as base, yielding secondary amine derivatives that serve as building blocks for kinase inhibitor analog libraries. The bromine atom at the 7-position remains intact throughout this transformation, providing a synthetic handle for subsequent Suzuki-Miyaura cross-coupling with aryl boronic acids using Pd(PPh₃)₄ (1-3 mol%) and aqueous sodium carbonate in a toluene/ethanol/water biphasic system at 80-85°C under inert atmosphere maintained by nitrogen sparging through a sintered glass frit at 50-80 mL/min. Process-scale execution is documented in pharmaceutical intermediate manufacturing under ICH Q7A Good Manufacturing Practice guidance, with impurity profiling per ICH Q3A guidelines requiring individual unspecified impurities not to exceed 0.10 area% by HPLC-UV at 254 nm and total impurities below 1.00 area%; residual palladium in the final intermediate must comply with Ph.Eur. monograph 2.4.20 limit of 10 ppm for oral drug substance precursors. The synthesis has been scaled to 50-200 kg batch sizes in glass-lined steel reactors with 2,000-5,000 L capacity, with the amination step requiring 18-24 hours at controlled internal temperature of 101-103°C and the subsequent Suzuki coupling completing within 4-6 hours at 80°C with toluene removed by vacuum distillation at 45-50°C/80-100 mbar prior to aqueous workup. Terminal API categories derived from this synthetic sequence include reversible Bruton's tyrosine kinase (BTK) inhibitors requiring 0.5-5.0 mg daily oral dosing, selective tropomyosin receptor kinase (TRK) fusion protein inhibitors for solid tumor indications, and adenosine A₂A receptor antagonists under investigation for Parkinson's disease where the 7-bromo substituent enhances metabolic stability toward hepatic CYP3A4-mediated oxidation compared with the corresponding 7-chloro and 7-fluoro congeners as assessed by human liver microsome intrinsic clearance assays incubated at 37°C with NADPH regeneration system for 60 minutes.

An analytically characterized decomposition pathway relevant to large-scale API intermediate storage involves photolytic debromination when the crystalline solid (melting point 82-84°C as determined by DSC at 5°C/min) is exposed to UV-A radiation (315-400 nm) at intensities exceeding 5 W/m² for cumulative doses above 200 kJ/m², generating 7-H-benzothiazole impurity detectable by GC-MS at retention time relative to the parent compound of 0.72 on a 30 m × 0.25 mm × 0.25 μm 5% phenyl methyl siloxane column with helium carrier at 1.2 mL/min. Storage specifications accordingly require amber glass containers or opaque HDPE drums with carbon black loading of 2.0-2.5 wt% to achieve optical density > 3.0 across the UV-A spectrum, stored at controlled room temperature 15-25°C with desiccant; retest dating assigned at 24 months from manufacturing based on ICH Q1A(R2) long-term stability protocol. The compound's limited aqueous solubility (0.12 mg/mL in water at 25°C as measured by shake-flask method with HPLC quantification) renders it unsuitable for direct formulation in parenteral dosage forms, and API synthesis routes in which the 7-bromo substituent is retained in the final active molecule must address this solubility limitation through salt formation, co-solvent systems, or amorphous solid dispersion technologies.

N-Alkylation of 7-Bromo-Benzothiazole with α-halocarbonyl electrophiles in dimethylformamide at 60-80°C using potassium carbonate base (1.5-2.5 equivalents) generates quaternary benzothiazolium salts that function as precursors to cyanine dyes for near-infrared fluorescence imaging probes. The reaction is conducted under anhydrous conditions with molecular sieves ( 3Å , activated at 300°C for 4 hours) present at 10 wt% relative to substrate mass, and product precipitation is induced by addition of diethyl ether antisolvent in a 5:1 volume ratio to DMF, with filtration through a 10-16 μm porosity sintered glass funnel under nitrogen pressure at 0.3-0.5 bar. The benzothiazolium bromide remains hygroscopic after isolation (Karl Fischer titration typically indicates 1.2-3.5 wt% residual moisture) and requires immediate conversion to the corresponding non-hygroscopic tetrafluoroborate or hexafluorophosphate salt via ion exchange in aqueous methanol for any application requiring storage beyond 72 hours. Published photophysical characterization for a representative pentamethine cyanine derived from 7-bromobenzothiazolium iodide indicates absorption λmax at 638 nm (ε = 1.42 × 10⁵ M⁻¹cm⁻¹) and emission λmax at 658 nm in phosphate-buffered saline, with the bromine substituent inducing a 12 nm bathochromic shift relative to the non-halogenated benzothiazolium analog, a property exploited in the design of bioorthogonal labeling reagents for super-resolution microscopy.

How Acidizing Corrosion Inhibitor Packages Exploit Thiazole Ring Adsorption on N80 Steel

Matrix acidizing operations in carbonate reservoirs deploying 15-28 wt% hydrochloric acid at bottomhole static temperatures (BHST) ranging from 80-140°C incorporate 7-Bromo-Benzothiazole as a film-forming corrosion inhibitor component at concentrations of 0.08-0.35 vol% of total stimulation fluid volume. The compound is typically co-formulated with propargyl alcohol and cinnamaldehyde-based synergists in a solvent package consisting of isopropanol and heavy aromatic naphtha, with the brominated benzothiazole contributing to inhibitor film persistence on N80 and L80 carbon steel tubulars under high-shear flow conditions exceeding 500 s⁻¹ as calculated at the tubing wall during bullheading operations at 8-15 bbl/min injection rates through 5-1/2 inch OD, 17-23 lb/ft casing. The heterocyclic nitrogen and sulfur atoms provide d-orbital coordination with the iron surface, while the 7-bromo substituent retards oxidative degradation of the adsorbed film by dissolved ferric ions (Fe³⁺) that accumulate in the spent acid due to dissolution of iron-bearing minerals, a degradation mode that limits conventional dibenzylidene acetone-based inhibitors to operational windows below 2,500 ppm dissolved iron. Compliance with oilfield chemical qualification protocols requires testing under NACE TM0169-2020 (standard weight-loss coupon method) using N80 steel coupons with surface finish of 0.8-1.2 μm Ra exposed to inhibited acid for 6 hours at the design BHST; acceptance criteria for deep gas wells typically stipulate weight-loss corrosion rates below 0.05 lb/ft² over the 6-hour exposure and absence of localized pitting exceeding 0.15 mm depth as measured by optical profilometry at 20× magnification. The formulated inhibitor package is metered into the acid stream via positive displacement chemical injection pumps downstream of the acid pump discharge, with static mixers providing 15-25 mixing elements to achieve uniform inhibitor dispersion prior to the fluid entering the wellhead; inadequate mixing manifesting as inhibitor phase separation in the coiled tubing string results in corrosion protection variability exceeding ±35% across different sections of the tubular string as verified by post-job caliper logging.

An incompatibility concern arises in acidizing operations where hydrogen sulfide (H₂S) partial pressure exceeds 0.05 psi in the production stream: the brominated benzothiazole undergoes nucleophilic displacement of the 7-bromo substituent by bisulfide ion (HS⁻) at downhole pH 3-5, yielding 7-mercaptobenzothiazole derivatives that exhibit significantly reduced film persistency and can precipitate as intractable solids upon spent acid neutralization during flowback when the pH exceeds 6.5, potentially contributing to fines migration and near-wellbore permeability impairment. Production-scale field data from acid treatments in the Khuff and Arab-D carbonate formations indicate that inhibitor loadings must be increased to 0.5-0.8 vol% when H₂S is anticipated at concentrations above 500 ppm in the reservoir gas cap, approximately 2.5-3× the dosage employed in sweet carbonate stimulation. Downstream products benefiting from this temporary corrosion protection include stimulated production wells with post-acidizing productivity indices (PI) exceeding pre-treatment values by 2-5×, gas condensate wells requiring acid diversion via viscoelastic surfactant-based self-diverting acid systems to achieve uniform stimulation across 50-200 m perforated intervals, and water injection wells where inhibitor residuals persisting in the formation for 24-48 hours post-flowback reduce oxygen-induced corrosion during the transition to produced water reinjection operations.

In industrial closed-loop cooling water systems treated with halogen-based biocides, 7-Bromo-Benzothiazole is evaluated as a copper alloy corrosion inhibitor for admiralty brass (C44300) and 90-10 copper-nickel (C70600) heat exchanger tubes at circulating water pH 7.8-8.8 and bulk water temperature of 30-45°C. The compound is dosed at 2-8 mg/L as active ingredient via diaphragm metering pumps into the cooling water return header, with continuous monitoring of free halogen residual maintained below 0.2 mg/L as Cl₂ to prevent oxidative debromination of the thiazole ring. Electrochemical linear polarization resistance (LPR) probes with copper electrodes measure corrosion rates in real time, with the brominated inhibitor achieving 0.008-0.015 mm/year penetration rates compared to 0.045-0.090 mm/year for uninhibited controls at equivalent halogen residuals, per ASTM D2688-15(2021) Method C. The primary limitation restricting broader adoption is the compound's aquatic toxicity profile: 96-hour LC₅₀ values for Daphnia magna fall in the range 0.8-2.1 mg/L as reported in publicly available ecotoxicological screening data, constraining use in cooling systems with once-through water sources or blowdown discharge to surface waters without wastewater treatment capable of activated carbon adsorption achieving >99% removal efficiency. Closed-loop recirculating systems with zero liquid discharge permits or access to municipal wastewater treatment plants with tertiary treatment represent the only operationally and environmentally viable deployment scenario.